SA has an article on NXP Semiconductor, the brains behind NFC mobile payments. There is no doubt that NFC is the payment method of the future and NXP seems to be the horse in the lead in this area.

The MF has also recommended buying shares as well.

It may be a long wait, but Pacific Biosciences is developing technology that could change the human genome game.

Link
Link

The Fool has a small piece summarizing a few penny Bio-Tech stocks out today. They seem most bullish on Aeterna Zentaris, a stock that has been covered numerous times over at Seeking Alpha. Another stock from the article is Zalicus, a company with only two drugs in development, both of which are in Phase II trials. The Fool is not too high on this stock since it only has the two drugs, but others are most certainly are. One article mentions that JMP Securities put a $5 price target on the stock at the end of March.

The Fool points out one gold miner that they think has been massively undervalued by the market. The article also has a link to a second article that points out other gold miners that appear to be undervalued.

The Fool looks at Power Secure, a small energy services company that appears to be on the brink of entering its high growth years. According to the valuation given in the article, shares should be worth about double their current price.

This person thinks so.

In this article, the MF called Qlik technologies the Best Tech Stock of 2011. In this article, the Fool explains that the company missed earnings as a result of hiring more employees, essentially willing to miss earnings targets now in order to blow them out of the water later.

Shares of Sketchers are cheap right now, and many think it is a good time to buy a piece of the #2 shoe retailer in the U.S.

A new article on Aeterna Zentaris argues that the stock has plenty of room to run and that shares have 200-300% upside.

The Fool makes a case for owning shares of Fidelity National Financial, the market leader in title insurance. This stock may require some patience as the market begins to appreciate the stock, but it does pay over a 3% dividend which may make waiting easier.